Status:
RECRUITING
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Lead Sponsor:
Michigan State University
Conditions:
Sepsis
Systemic Inflammatory Response Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this project is to test the utility of The Gene Z device (as of 2018 Gene Z no longer being used), now using In-Dx and other rapid identification techniques that the investigators have deve...
Detailed Description
Dramatic improvement in the timely and effective treatment of patients afflicted with sepsis can be achieved with the implementation of modern technologies for identification of offending microbial sp...
Eligibility Criteria
Inclusion
- Adult patients with 3 of 4 systemic inflammatory response syndrome (SIRS) characteristics (1. tachycardia, 2. fever or hypothermia, 3. tachypnea, 4. leukocytosis), who have blood cultures drawn and urine collected for the evaluation of suspected sepsis, and/or other bodily fluids collected for culture and sensitivity analysis.
- Patients with other sources of infection with less than 3 of 4 SIRS criteria
Exclusion
- Pediatric patients
Key Trial Info
Start Date :
June 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2032
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT01904188
Start Date
June 1 2015
End Date
July 1 2032
Last Update
May 23 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Health/Sparrow (name change only)
Lansing, Michigan, United States, 48909
2
McLaren Greater Lansing
Lansing, Michigan, United States, 48910